| US1189734-1ML | 189734-1ML | STREPTAVIDIN, FLUORESCEIN CONJUGATE |
| US1189737-1ML | 189737-1ML | STREPTAVIDIN, PHYCOERYTHRIN CONJUGATE |
| US1189738-1ML | 189738-1ML | STREPTAVIDIN, TEXAS RED CONJ |
| US1189739-1ML | 189739-1ML | STREPTAVIDIN AGAROSE SUSPENSION |
| US1189742-5ML | 189742-5ML | AVIDIN, AGAROSE CONJUGATE |
| US1189825-25MG | 189825-25MG | 5-AZA-2-DEOXYCYTIDINE |
| US11="border-bottom: windowtext 0.5pt solid; border-left: windowtext; background-color: transparent; border-top: windowtext; border-right: windowtext 0.5pt solid">BAX-INHIBITING PEPTIDE, NEGATIVE CONTROL |
| US1196821-100UL | 196821-100UL | ANTI-BAX (44-62) RABBIT PAB |
| US1196870-10MG | 196870-10MG | BAY 11-7082 |
| US1196871-10MG | 196871-10MG | INSOLUTION(TM) BAY 11-7082 |
| US1196872-10MG | 196872-10MG | BAY 11-7085 |
| US1196876-5MG | 196876-5MG | BAY 41-2272 |
| US1196878-1MG | 196878-1MG | (+/-)-BAY K 8644 |
| US1196878-5MG | 196878-5MG | (+/-)-BAY K 8644 |
| US1197209-100UG | 197209-100UG | ANTI-BCL-W (16-29) RABBIT PAB |
| US1197210-50NMOL | 197210-50NMOL | BCL-2 ANTISENSE OLIGONUCLEOTIDE, CONTROL |
| US1197217-1MG | 197217-1MG | BCL-XL BH4(4-23) (HUMAN), CELL-PERMEABLE |
| US1197220-1MG | 197220-1MG | BCL-2 BINDING PEPTIDE, CELL-PERMEABLE |
| US1197221-5MG | 197221-5MG | BCR-ABL INHIBITOR |
| US1197222-6000U | 197222-6000U | BCL-10, HIS-TAG, HUMAN, WILD TYPE, RECOM |
| US1197223-5MG | 197223-5MG | BCR-ABL INHIBITOR II |
| US1197225-1MG | 197225-1MG | BCL-2 BINDING PEPTIDE, NEG. CONTROL |
| US1197320-2MG | 197320-2MG | BCL-2 CONVERTER,D-NUBCP-9-R8,CELL-PERMEA |
| US1197330-5MG | 197330-5MG | BCL-2 INHIBITOR |
| US1197331-5MG | 197331-5MG | BCL-2 INHIBITOR II, YC137 |
| US1197332-10MG | 197332-10MG | BCL-2 INHIBITOR III |
| US1197333-5MG | 197333-5MG | BCL-2 INHIBITOR VI, ABT-737 |
| US1197900-5MG | 197900-5MG | BEC, HYDROCHLORIDE |